Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in the US market. The company has received tentative approval from the US ...

Dr. Shahin Fesharaki, Global Chief Scientific Officer, Lupin, said, "This recognition underscores our dedication to advancing science and highlights Nanomi's pioneering efforts in drug delivery.